Nanosphere (NSPH) soars 19.1% into the stratosphere and hits $3.02 as Jefferies upgrades the company to buy from hold. Jefferies expects the firm's bloodstream infection test, which the FDA approved last week, to "drive a significant acceleration in new system placements and revenue." Jefferies also ups NSPH's price target to $5/share from $2.
Nanosphere (NSPH) soars 19.1% into the stratosphere and hits $3.02 as Jefferies upgrades the...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs